Jones Financial Companies
VYGR icon

Jones Financial Companies’s Voyager Therapeutics VYGR Stock Holding History

Jones Financial Companies’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$297 Sell
75
-155
-67% -$610 ﹤0.01% 4560
2025
Q4 		$904 Hold
230
– – ﹤0.01% 4042
2025
Q3 		$1.04K Hold
230
– – ﹤0.01% 3883
2025
Q2 		$681 Buy
230
+75
+48% +$242 ﹤0.01% 3743
2025
Q1 		$566 Hold
155
– – ﹤0.01% 3496
2024
Q4 		$879 Hold
155
– – ﹤0.01% 3159
2024
Q3 		$907 Hold
155
– – ﹤0.01% 2825
2024
Q2 		$1.23K Buy
+155
New +$1.3K ﹤0.01% 2253

Other funds holding VYGR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Jones Financial Companies's VYGR Position: Q1 2026 in Review

Jones Financial Companies reduced its Voyager Therapeutics (VYGR) stake by 67% in Q1 2026, selling an estimated $610 and leaving 75 shares worth $297. The position accounts for ﹤0.01% of the portfolio, ranked #4560.

Jones Financial Companies first reported a position in VYGR in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.23K in Q2 2024. 135 funds tracked by Wall St. Rank hold VYGR as of Q1 2026.

  • Jones Financial Companies held 75 shares of Voyager Therapeutics worth $297 as of Q1 2026.
  • Jones Financial Companies sold 155 Voyager Therapeutics shares in Q1 2026, an estimated $610.
  • Voyager Therapeutics made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #4560 holding.
  • Jones Financial Companies first reported a position in Voyager Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • Jones Financial Companies's Voyager Therapeutics position peaked at $1.23K in Q2 2024.
  • 135 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.